Long-term real-world effectiveness of carbidopa/levodopa enteral suspension after 36 months of treatment initiation in advanced Parkinson's disease in the US: final results from the PROviDE study

Clinical Parkinsonism & Related Disorders · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles